Christopher N. Floyd

Hypertension in adults: summary of updated NICE guidance

Rebecca J Boffa, Margaret Constanti, Christopher N. Floyd et al. · BMJ · 2019 · 92 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

Emma Magavern, Juan Carlos Kaski, Richard M. Turner et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2021 · 49 citations · Full text

Medicine, Cardiology, Pharmacology +17

Indications for anticoagulant and antiplatelet combined therapy

Christopher N. Floyd, Albert Ferro · BMJ · 2017 · 45 citations · Full text

Medicine, Cardiology, Pharmacology +12

Increased platelet expression of glycoprotein <scp>IIIa</scp> following aspirin treatment in aspirin‐resistant but not aspirin‐sensitive subjects

Christopher N. Floyd, Timothy Goodman, Silke Becker et al. · British Journal of Clinical Pharmacology · 2014 · 25 citations · Full text

Medicine, Hematology, Pharmacology +16

Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk

Margaret Constanti, Christopher N. Floyd, Mark Glover et al. · Hypertension · 2020 · 23 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17